Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California. Show more
Location: 701 Anacapa Street, Santa Barbara, CA, 93101, United States | Website: https://phytanix.com | Industry: Biotechnology | Sector: Healthcare
Market Cap
4.029M
52 Wk Range
$1.83 - $14.28
Previous Close
$2.10
Open
$2.09
Volume
23,811
Day Range
$2.01 - $2.10
Enterprise Value
3.85M
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
11.21%
Institutional Own.
10.11%
Qtr Updated
03/31/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
PT00114 Details Major depression, anxiety disorders, PTSD, addiction / substance use disorders | Phase 1/2 Data readout |
